Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.

× No keyword cloud information.

8 in total

Review 1. [Diabetic kidney disease - Update 2016].

Authors: Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal: Wien Klin Wochenschr Date: 2016-04 Impact factor: 1.704

Review 2. The forgotten type 2 diabetes mellitus medicine: rosiglitazone.

Authors: Bo Xu; Aoxiang Xing; Shuwei Li
Journal: Diabetol Int Date: 2021-06-29

Review 3. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development.

Authors: Fan Hong; Pengfei Xu; Yonggong Zhai
Journal: Int J Mol Sci Date: 2018-07-27 Impact factor: 5.923

Review 4. Thiazolidinediones: the Forgotten Diabetes Medications.

Authors: Harold E Lebovitz
Journal: Curr Diab Rep Date: 2019-11-27 Impact factor: 4.810

Review 5. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios.

Authors: Swati Katoch; Vinesh Sharma; Vikram Patial
Journal: World J Gastroenterol Date: 2022-07-28 Impact factor: 5.374

6. Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP.

Authors: Christine R Swanson; Eric Du; Delinda A Johnson; Jeffrey A Johnson; Marina E Emborg
Journal: PPAR Res Date: 2013-10-02 Impact factor: 4.964

7. CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.

Authors: Yue Ming; Xiangnan Hu; Ying Song; Zhiguo Liu; Jibin Li; Rufei Gao; Yuyao Zhang; Hu Mei; Tingwang Guo; Ling Xiao; Bochu Wang; Chaodong Wu; Xiaoqiu Xiao
Journal: PLoS One Date: 2014-07-08 Impact factor: 3.240

8. Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.

Authors: Hua Qu; Yi Zheng; Yuren Wang; Rui Zhang; Xiongzhong Ruan; Gangyi Yang; Zhenqi Liu; Hongting Zheng
Journal: Sci Rep Date: 2017-11-17 Impact factor: 4.379

8 in total